Search
    Skip to main content
    Advertisement

    Pharmaceuticals

    1. Business
    2. Pharmaceuticals
    Novo Nordisk stock falls on surprise CEO departure Yahoo! US07:57
    1 Beaten-down stock to buy right now, and 1 to avoid The Motley Fool05:38
    Are regulators keeping pace with AI adoption in clinical trials? Pharmaceutical Technology05:07
    EU Scandal Alert: Von der Leyen’s Secret Pfizer Chats Exposed by Court Ruling Novinite03:11
    Struggling healthcare company files for Chapter 11 bankruptcy The Fresno Bee22:21
    BioMarin makes Phase 3 buy, paying $270M for rare disease outfit Inozyme ENDPOINTS11:12
    Executives on the move: Pathos procures CEO from AstraZeneca, new CEO for tme pharma, and more Scrip Pharma Intelligence10:09

    Latest News

    In the last 15 minutes
    USFDA completes GMP inspection of Dr Reddy's Middleburgh facility in New York The Business Standard02:26
    In the last 6 hours
    Struggling healthcare company files for Chapter 11 bankruptcy The Fresno Bee22:21 16-May-25
    BREAKING: J&J Unit Hit With $147M Verdict In Catheter Antitrust Suit Law36022:05 16-May-25
    STAT Plus: At gene therapy meeting, no one wants to talk about the Vinay Prasad (not) in the… STAT21:58 16-May-25
    FDA clears first blood test to diagnose Alzheimer’s disease Pittsburgh Tribune-Review21:13 16-May-25
    Trump Administration Announces New Executive Order to Promote Domestic Production of Biopharmaceuticals JD Supra20:46 16-May-25
    In the last 8 hours
    Life-saving healthcare company files for Chapter 11 bankruptcy The Fresno Bee20:29 16-May-25
    Focused ultrasound halts growth of debilitating brain lesions ScienceDaily20:09 16-May-25
    A Short History Of MASH Deals, Culminating In GSK/Boston Pharma Scrip Pharma Intelligence19:59 16-May-25
    LA Times Owner Joins Trump, Crown Prince At Saudi Summit Patch19:59 16-May-25
    BioMarin’s $270m Inozyme Buy Fits Right Into Enzyme Therapy Business Scrip Pharma Intelligence19:29 16-May-25
    UK immigration reform – implications for life sciences European Pharmaceutical Review19:00 16-May-25
    Illumina Accuses Ex-Workers' Co. Of Infringing Gene Tech IP Law36018:52 16-May-25
    Yesterday
    $44M Birmingham Federal Biotech Grant Gets Rescinded Government Technology18:04 16-May-25
    First blood test for Alzheimer’s diagnosis cleared by FDA Fox News18:02 16-May-25
    $44 million Birmingham Biotech Hub grant rescinded Alabama Daily News17:55 16-May-25
    Ozempic boss axed in battle of the fat jabs MailOnline17:53 16-May-25
    Lilly Endowment Hits $80 Billion, Topping Gates as Largest in US (1) Bloomberg Law17:36 16-May-25
    Why Viking Therapeutics Stock Bumped 3% Higher Today The Motley Fool17:30 16-May-25
    Regeneron Wins PCSK9 Court Battle Against Amgen Scrip Pharma Intelligence17:27 16-May-25
    Pharmacists stockpile most common drugs on chance of Trump tariffs Tucson Sentinel17:25 16-May-25
    Ozempic-Maker CEO Ousted Over Pharma Company’s Rocky Market Downturn Gizmodo17:23 16-May-25
    Boss of Ozempic maker axed in battle of the fat jabs: Lars Fruergaard Jorgensen forced out after pressure put on board This is Money16:57 16-May-25
    FDA clears 1st blood test to help diagnose Alzheimer's disease ABC News16:56 16-May-25
    Reflections on the FDLI 2025 Annual Conference – Differing Tones, Shared Goals National Law Review16:51 16-May-25
    Can a new CEO fix Novo Nordisk's problems? This analyst says no. Yahoo! UK & Ireland16:41 16-May-25
    FDA Approved NDA for Aficamten to Treat Patients With Obstructive Hypertrophic Cardiomyopathy Pharmacy Times16:27 16-May-25
    FDA OKs first blood test that can help diagnose Alzheimer's disease MailOnline16:18 16-May-25
    Weighing approval bids from J&J, Pfizer and Roche, FDA scrutinizes data ahead of adcomm FiercePharma16:13 16-May-25
    Novo Nordisk ousts CEO ShareCafe16:10 16-May-25
    FDA Approves First Blood Test to Diagnose Alzheimer’s Disease Mint16:08 16-May-25
    FDA clears first blood test for diagnosing Alzheimer’s STAT16:05 16-May-25
    It's true: it doesn't get any chicer than Demi Moore's white turn-up jeans and comfy Teva… Woman and Home16:02 16-May-25
    Novo Nordisk should look to the US for its next CEO, analysts say Mint15:57 16-May-25
    Sarepta seeks to expand Duchenne gene therapy Elevidys use to toddlers ENDPOINTS15:57 16-May-25
    Eli Lilly pulls ahead of Novo in obesity drug gold rush as new players crowd in Invezz15:56 16-May-25
    Exclusive STAT15:55 16-May-25
    STAT Plus: UnitedHealth’s Optum working on Medicare risk scoring system that would use AI STAT15:55 16-May-25
    Analysis-Novo Nordisk should look to the US for its next CEO, analysts say Yahoo! UK & Ireland15:51 16-May-25
    FDA Greenlights Blood Test To Diagnose Alzheimer’s—The First Of Its Kind Forbes15:50 16-May-25
    HHS can require approval for drugmakers to apply 340B rebate models, court rules ENDPOINTS15:47 16-May-25
    100 Days In: FDA Updates and Trends to Watch JD Supra15:40 16-May-25
    House Judiciary Investigating Whether Pfizer Sought To Influence 2020 Election Results The Daily Caller15:35 16-May-25
    HHS, DARPA link up with Rutgers, Cost Plus Drugs and others in initiative to rethink US drug… FiercePharma15:22 16-May-25
    'Irrational' fixed dose combos harmful, may face ban: Expert panel The Times of India15:19 16-May-25
    US FDA clears first blood test to detect Alzheimer's disease The Economic Times15:08 16-May-25
    Eli Lilly strikes $1.3bn gene therapy deal with Rznomics Pharmaceutical Technology15:08 16-May-25
    Evaluation of Antibiotic Administration Surrounding Interventional Radiology Procedures Pharmacy Times14:56 16-May-25
    Bavarian companies forge new ties with India The Times of India14:54 16-May-25
    Market movers: Supermicro, Virgin Galactic, Cava Group, Novo Nordisk... Proactive Investors (Canada)14:43 16-May-25
    Is Novo Nordisk Stock a Buy, Sell, or Hold as CEO Lars Fruergaard Jørgensen Resigns? Barchart14:39 16-May-25
    Third Circuit Affirms Rejection of AstraZeneca’s Challenges to IRA Drug Price Negotiation Program JD Supra14:39 16-May-25
    Piramal Pharma to stay away from prescription business in India: Nandini Piramal The Times of India14:28 16-May-25
    Novo Nordisk’s CEO Departure Marks Inflection Point for Struggling Pharma Giant Investing.com UK14:28 16-May-25
    From insulin to Ozempic, history of Novo Nordisk's CEOs Yahoo! US14:25 16-May-25
    Cooley, Goodwin Build BioMarin's $270M Inozyme Buy Law36014:17 16-May-25
    FDA Approves Auto-Injector for Migraine, Cluster Headache Medpage Today14:16 16-May-25
    Adding Pertuzumab to Trastuzumab and Chemotherapy Reduced Risk of Death by 17% in HER2+ Breast Cancer Pharmacy Times14:15 16-May-25
    Delivering Hope: Building a Network for Radioligand Therapies FiercePharma14:11 16-May-25
    House lawmakers probe claim Pfizer delayed COVID vaccine data until after 2020 election FiercePharma14:11 16-May-25
    The remarkable timeline of a custom gene-editing therapy to save a newborn Ars Technica14:05 16-May-25
    Lupin CEO On Trump’s Most Favored Nation Policy, Tariffs, Firm’s Five-Year Plan Scrip Pharma Intelligence14:03 16-May-25
    Deputy FDA chief mulls shaking up PDUFA reauthorization structure ENDPOINTS13:55 16-May-25
    CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop The Washington Times13:54 16-May-25
    Trump Executive Orders seek to encourage reshoring of pharmaceutical manufacturing and research Health Industry Washington Watch13:50 16-May-25
    'Manhood' Author Asked Brain Worm Host to Use Bogus Right-Wing 'Study' to Restrict Abortion Pills Jezebel13:48 16-May-25
    FDA raises issues with four cancer drugs ahead of adcomm ENDPOINTS13:45 16-May-25
    Lupin CEO On Trump’s Most Favored Nation Policy, Firm’s Five-Year Plan Scrip Pharma Intelligence13:42 16-May-25
    Executive Order Calls for Most-Favored-Nation Pharmaceutical Pricing for American Patients JD Supra13:28 16-May-25
    Lupin CEO On Trump’s Most Favored Nation Policy, Pill Penalty And Five-Year Plan Scrip Pharma Intelligence13:22 16-May-25
    Galaxy Digital on the Nasdaq, Novo ousts CEO, Virgin Galactic Yahoo! UK & Ireland13:18 16-May-25
    Novo Nordisk CEO to exit role European Pharmaceutical Review13:08 16-May-25
    ACOG Releases New Pain Management Recommendations for IUD Insertions Pharmacy Times12:54 16-May-25
    Amarin urges Supreme Court to decline Hikma's drug label spat ENDPOINTS12:54 16-May-25
    Pfizer faces accusations over timing of Covid vaccine results Fox News12:53 16-May-25
    Ozempic-maker Novo Nordisk ousts CEO after shares plummet ABC Online12:51 16-May-25
    Executive Order Seeks to Eliminate Discrepancies in Drug Pricing Between United States and Other Countries JD Supra12:48 16-May-25
    Advocate for Change to Address Pharmacy Burnout Pharmacy Times12:44 16-May-25
    Several Comorbidities Found to Reduce Likelihood of Pneumococcal Vaccination, While Use of Implantable Devices… Pharmacy Times12:44 16-May-25
    Novo Nordisk CEO to step down amid market challenges and stock plunge The Times of India12:44 16-May-25
    Abbott (ABT) Up 1.8% Since Last Earnings Report: Can It Continue? Zacks12:34 16-May-25
    Novo Nordisk ousts CEO after falling behind in weight loss market Deccan Herald12:34 16-May-25
    #ASGCT25: Lower conference attendance mirrors challenged cell and gene field ENDPOINTS12:34 16-May-25
    Novo Nordisk’s CEO Forced Out After Falling Behind In GLP-1 Battle Scrip Pharma Intelligence12:31 16-May-25
    Gilead Sciences (GILD) is Flashing a Quant Signal That Wall Street is Ignoring Money Morning12:24 16-May-25
    Wegovy firm unexpectedly forces boss to step down BBC12:23 16-May-25
    Durvalumab Regimen Improves Disease-Free Survival in High-Risk Non-Muscle-Invasive Bladder Cancer Pharmacy Times12:14 16-May-25
    Omalizumab: An All-in-One Allergy Wonder Drug? Pharmacy Times12:14 16-May-25
    Ignore the Noise: Why Quant-Minded Traders Should Keep Close Tabs on Merck (MRK) Money Morning12:14 16-May-25
    In Brief: US FDA Delay Sends Biohaven Shares Down Scrip Pharma Intelligence12:11 16-May-25
    ‘Sons of the Neon Night’ Director Juno Mak Breaks Down His Hong Kong Crime Thriller: ‘There’s a Nightmarish Poetry to… Variety12:04 16-May-25
    Incyte Gets FDA Approval for Zynyz in New Cancer Indication Zacks12:04 16-May-25
    In surprise move Wegovy-maker Novo Nordisk ousts CEO amid sagging sales Al Jazeera11:52 16-May-25
    Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90% Benzinga11:46 16-May-25
    Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs Medpage Today11:43 16-May-25
    Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now? Zacks11:34 16-May-25
    #ASGCT25: In three patients, Rocket’s second heart gene therapy shows promise ENDPOINTS11:33 16-May-25
    After 19 months, FDA lifts clinical hold on vaginal yeast infection drug Brexafemme FiercePharma11:29 16-May-25
    Mark Cuban compounder joins Trump's new manufacturing initiative ENDPOINTS11:22 16-May-25
    Novo Nordisk CEO will step down amid falling share price and 'recent market challenges' UPI11:20 16-May-25
    New Executive Order Aims for Most-Favored Nation Pricing: John Barkett, MBA American Journal of Managed Care11:19 16-May-25
    Why Novo Nordisk Stock Just Slipped The Motley Fool11:13 16-May-25
    BioMarin makes Phase 3 buy, paying $270M for rare disease outfit Inozyme ENDPOINTS11:12 16-May-25
    Commentary: Drug makers sanctioned for overcharging low-cost meds to underserved communities Grand Forks Herald11:08 16-May-25
    Modelling biologics: Challenges and opportunities, with Dr D... pharmaphorum11:05 16-May-25
    With marketing chief's departure, Omnicom Health loses another exec ahead of Interpublic merger FiercePharma10:59 16-May-25
    UK Biotech Biz Issues Shares To Fund £5M Canadian Buy Law36010:53 16-May-25
    FDA approves Amneal’s DHE migraine/cluster headache autoinjector Pharmaceutical Technology10:53 16-May-25
    Revamping US pharma manufacturing: Trump’s executive order faces industry doubts Pharmaceutical Technology10:53 16-May-25
    Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock Zacks10:53 16-May-25
    Novo CEO to depart as obesity drugmaker’s challenges rise BioPharma Dive10:43 16-May-25
    Here's Why Novartis (NVS) is a Strong Value Stock Zacks10:43 16-May-25
    The Role of Specialty Pharmacists in Managing Chronic Kidney Disease Pharmacy Times10:42 16-May-25
    WuXi Biologics slims down again, handing off German plant to CDMO Terumo for $167M FiercePharma10:38 16-May-25
    Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills HealthDay10:35 16-May-25
    view more headlines
    17 May 02:26

    About our Pharmaceuticals news

    NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
    Read more

    Business Top Stories

    Moody’s strips U.S. government of top credit rating over failure to rein in debt PBS Online19:22National Debt Economy Business (US)
    U.S. Downgraded by Moody’s as Trump pushes costly tax cuts The Fresno Bee20:39National Debt Economy Business (US)
    This Artificial Intelligence (AI) chip stock is making a big move, and it has the potential to soar higher The Motley Fool17:40Apple Top Tech Brands India
    Why Making iPhones in the US Is a ‘Non-Starter,' Wedbush Says, as Trump Pressures Apple Yahoo! US14:56Apple Top Tech Brands India
    Coinbase boosted by S&P 500 inclusion despite hack, probe risks Yahoo! US18:10Hacking Coinbase Crypto
    Coinbase hack may cost company $400M, rocks crypto pioneer Insurance Claims Journal12:04Hacking Coinbase Crypto
    US consumer sentiment drops to near record low in May on inflation worries, tariff uncertainty Fox News16:57US Economy Economy Business (US)
    Trading Day: Market elation trumps brewing stagflation Yahoo! US16:48US Economy Economy Business (US)
    Bitcoin has been 'report card on fiscal stewardship': Mike Novogratz Yahoo! US17:08Mike Novogratz Nasdaq Markets
    Public Keys: Can’t Hold Coinbase Back, Nasdaq Initiation for eToro and Galaxy Digital Decrypt16:14Mike Novogratz Nasdaq Markets
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.